Hematology News and Research

RSS

Hematology, also spelled haematology, is the branch of biology (physiology), pathology, clinical laboratory, internal medicine, and pediatrics that is concerned with the study of blood, the blood-forming organs, and blood diseases. Hematology includes the study of etiology, diagnosis, treatment, prognosis, and prevention of blood diseases.

Older patients with colorectal cancer at increased risk of cardiovascular morbidity

Older patients with colorectal cancer are at an increased risk of developing cardiovascular disease and congestive heart failure, according to a study published in Journal of Clinical Oncology.

16 Mar 2018

UCLA-developed nanospears could make gene therapies safer, faster and more cost-effective

UCLA scientists have developed a new method that utilizes microscopic splinter-like structures called "nanospears" for the targeted delivery of biomolecules such as genes straight to patient cells. These magnetically guided nanostructures could enable gene therapies that are safer, faster and more cost-effective.

15 Mar 2018

Electronic consultation system reduces wait times, increases access to specialty care

An electronic consultation system designed to reduce excessive wait times for appointments with specialists experienced exponential growth during a recent five-year period.

13 Mar 2018

Poorer socioeconomic status linked to lower survival from anal cancer

If you are from a lower income area, your chances of surviving anal cancer are significantly reduced, according to a new study led by investigators at NYU Langone Health's Perlmutter Cancer Center, and publishing online March 12, 2018 in Cancer.

12 Mar 2018

UNC Lineberger study identifies genetic clues that explain how breast cancer metastasizes

Breast cancer is the second leading cause of cancer death in women in the United States, with most deaths caused by the cancer spreading beyond the breast.

6 Mar 2018

Study reveals HCT as effective treatment for NHL patients regardless of age

Results from a retrospective study of 1,629 patients with non-Hodgkin lymphoma showed that survival at 4 years following allogeneic hematopoietic cell transplantation for patients age 65 years and older is comparable to patients age 55 to 64 years.

21 Feb 2018

Blood or marrow transplantation survivors have higher risk of cognitive impairment

Allogeneic blood or marrow transplantation recipients are at a significantly higher risk of cognitive impairment in the years post-transplantation, according to a study published in Journal of Clinical Oncology.

20 Feb 2018

FDA approves first treatment to reduce risk of NSCLC progression

The U.S. Food and Drug Administration today approved Imfinzi (durvalumab) for the treatment of patients with stage III non-small cell lung cancer (NSCLC) whose tumors are not able to be surgically removed (unresectable) and whose cancer has not progressed after treatment with chemotherapy and radiation (chemoradiation).

18 Feb 2018

New guidelines offer recommendations for assessment, management of immunotherapy side effects

Immunotherapy with immune checkpoint inhibitors is the first of a new generation of immunotherapy treatments, revolutionizing treatment for many different types of cancer. By unleashing the body's immune system to attack cancer, these treatments can send even the most hard-to-treat cancers into lasting remission.

15 Feb 2018

FDA approves new treatment for non-metastatic, castration-resistant prostate cancer

The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant). This is the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer.

15 Feb 2018

Report identifies potentially modifiable factors that may contribute to persistent risk of SUID

An analysis of trends in sudden unexpected infant death (SUID) over the past two decades finds that the drop in such deaths that took place following release of the 1992 American Academy of Pediatrics (AAP) "back to sleep" recommendations, did not occur in infants in the first month of life.

14 Feb 2018

Health indicators for children born to breast cancer survivors may depend on cancer type

For breast cancer survivors, the risk of giving birth prematurely, and for other health concerns for their newborns, may depend on the type of breast cancer they had, according to a study from University of North Carolina Lineberger Comprehensive Cancer Center researchers.

6 Feb 2018

UAMS Myeloma Institute expert compiles new book on Castleman disease

Castleman disease, a rare disorder of the lymph nodes and related tissues, was identified and named more than a half-century ago but, until recently, no one had written a book exclusively about it.

30 Jan 2018

FDA approves new radioactive drug for treatment of rare digestive tract cancers

The U.S. Food and Drug Administration today approved Lutathera (lutetium Lu 177 dotatate) for the treatment of a type of cancer that affects the pancreas or gastrointestinal tract called gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

29 Jan 2018

$500 cancer detection blood tests may soon become reality

According to latest breakthrough in research, a blood test to detect eight common cancers, even before their symptoms begin to appear, may become a reality soon. The study report appears in the latest issue of the journal Science and gives hope for early detection of these deadly diseases when it could still be treated more effectively.

18 Jan 2018

FDA grants approval for first drug to treat inherited breast cancer

The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer, and it is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a "BRCA" gene mutation.

15 Jan 2018

UC scientists identify protein that acts as mediator of HER2-driven breast cancer

Researchers at the University of Cincinnati College of Medicine have identified for the first time that the estrogen receptor-binding protein MED1 is a critical mediator of HER2-driven breast cancer, identifying it as a potential therapeutic target.

9 Jan 2018

UC Davis expert expresses caution on genetically engineered HSCs

In a commentary published in the Jan. 4 issue of the New England Journal of Medicine, UC Davis researcher William Murphy expressed cautious optimism about efforts to genetically engineer hematopoietic stem cells (HSCs) to temporarily resist cell death during transplantation.

4 Jan 2018

Macrophages play major role in helping early breast cancer cells spread even before tumor develops

Mount Sinai researchers have discovered that normal immune cells called macrophages, which reside in healthy breast tissue surrounding milk ducts, play a major role in helping early breast cancer cells leave the breast for other parts of the body, potentially creating metastasis before a tumor has even developed, according to a study published in Nature Communications.

2 Jan 2018

Proteasome inhibitor treatment can lead to cardiovascular problems in multiple myeloma patients

The proteasome inhibitor carfilzomib has taken on an increasing role in the treatment of multiple myeloma, but new research from the Abramson Cancer Center of the University of Pennsylvania shows the therapy comes with the risk of cardiovascular problems in a higher than expected percentage of patients.

28 Dec 2017

Hematology News and Research

Further Reading

Older patients with colorectal cancer at increased risk of cardiovascular morbidity

UCLA-developed nanospears could make gene therapies safer, faster and more cost-effective

Electronic consultation system reduces wait times, increases access to specialty care

Poorer socioeconomic status linked to lower survival from anal cancer

UNC Lineberger study identifies genetic clues that explain how breast cancer metastasizes

Study reveals HCT as effective treatment for NHL patients regardless of age

Blood or marrow transplantation survivors have higher risk of cognitive impairment

FDA approves first treatment to reduce risk of NSCLC progression

New guidelines offer recommendations for assessment, management of immunotherapy side effects

FDA approves new treatment for non-metastatic, castration-resistant prostate cancer

Report identifies potentially modifiable factors that may contribute to persistent risk of SUID

Health indicators for children born to breast cancer survivors may depend on cancer type

UAMS Myeloma Institute expert compiles new book on Castleman disease

FDA approves new radioactive drug for treatment of rare digestive tract cancers

$500 cancer detection blood tests may soon become reality

FDA grants approval for first drug to treat inherited breast cancer

UC scientists identify protein that acts as mediator of HER2-driven breast cancer

UC Davis expert expresses caution on genetically engineered HSCs

Macrophages play major role in helping early breast cancer cells spread even before tumor develops

Proteasome inhibitor treatment can lead to cardiovascular problems in multiple myeloma patients

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo